Pakistan Set for $80 Million Pharmaceutical Investment From Russia
May 14, 2026
No Comments
Read More »
A Russian pharmaceutical company plans to invest nearly $80 million in Pakistan to establish local insulin production facilities, marking a major development for the country’s healthcare and pharmaceutical sectors. Zavod Medsintez and its Pakistani partner Genetics Pharmaceuticals Private Limited intend to launch the project in two phases, according to officials
